引用本文:陈石卿.舒芬太尼复合罗哌卡因在产科硬膜外自控镇痛中的应用[J].中国临床新医学,2010,3(5):450-452.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1248次   下载 880 本文二维码信息
码上扫一扫!
分享到: 微信 更多
舒芬太尼复合罗哌卡因在产科硬膜外自控镇痛中的应用
陈石卿
423000 湖南郴州,湘南学院附属医院麻醉科
摘要:
[摘要] 目的 探讨舒芬太尼复合罗哌卡因在产科硬膜外自控镇痛(PCEA)中的应用。方法 选择90例腰硬联合麻醉下行剖宫产的产妇,随机分为三组(n=30)。分别应用0.2 μg/ml舒芬太尼+0.125%罗哌卡因(A组),0.4 μg/ml舒芬太尼+0.125%罗哌卡因(B组),0.6 μg/ml舒芬太尼+0.125%罗哌卡因(C组)。术后行PCEA,即负荷剂量(5 ml)+持续剂量(3 ml/h)+PCA剂量(1 ml/次)。比较分析术后0~、3~、6~、12~24h 各时段切口痛、宫缩痛的VAS评分;24 h内不良反应发生率(恶心、呕吐、瘙痒、运动阻滞、嗜睡、呼吸抑制)。结果 术后PCEA,24 h内随舒芬术尼浓度增大,切口痛VAS评分和宫缩痛VAS评分降低,其中B组、C组与A组评分比较差异有统计学意义(P<0.05),B组与C组VAS评分比较差异无统计学意义(P>0.05)。24 h内不良反应中恶心、瘙痒的发生率随舒芬太尼浓度的增大而增多,其中C组与B组、A组比较差异有统计学意义(P<0.05),B组与A组两者比较差异无统计学意义(P>0.05)。三组的呕吐、运动阻滞、嗜睡情况比较,差异无统计学意义(P>0.05),未发生呼吸抑制。结论 剖宫产术后PCEA,0.4μg/ml舒芬太尼复合0.125%罗哌卡因可取得较好的镇痛效果和较少的副作用。
关键词:  硬膜外镇痛  舒芬太尼  剖宫产
DOI:10.3969/j.issn.1674-3806.2010.05.12
分类号:R 614.4
基金项目:
Application of sufentanil combined with ropivacaine for obstetric epidural analgesia in the cesarean section patients
CHEN Shi-qing
Department of Anesthesiology, the Affiliated Hospital of Xiangnan University, Chenzhou Hunan 423000, China
Abstract:
[Abstract] Objective To explore the application of sufentanil combined with ropivacaine for obstetric epidural analgesia in the cesarean section patient controlled epidural analgesia(PCEA). Methods Ninety cases of cesarean section were randomly divided into three groups with spinal-epidural anesthesia, i.e. group A, group B and group C. There were 30 cases in each group. The patients received 0.2 μg/ml sufentanil combined with 0.125% ropivacaine in group A, 0.4 μg/ml sufentanil combined with 0.125% ropivacaine in group B and 0.6 μg/ml sufentanil combined with 0.125% ropivacaine in group C, respectively. Postoperative PCEA were performed through loading dose (5 ml) + continuous dose (3 ml/h) + PCA dose (1 ml/times). The data were analyzed on the VAS scoring of incision pain, uterine pain in the period of 0~3, 3~6, 6~12, 12~24 h postoperatively and the incidence of adverse reactions such as nausea, vomiting, itching, motor block, lethargy, respiratory depression in the period of 0~24 h postoperatively. Results The incision pain VAS score and contraction VAS pain score decreased with sufentanil concentration increasing. The defference between Group B, group C and Group A had statistic significance(P<0.05). The defference between Group B and group C had not statistic significance (P>0.05). The rate of adverse reactions in the nausea and the incidence of itching increased with sufentanil concentration increasesing. The defference between Group C and group B, Group A had statistic significance(P<0.05). The defference between Group B and group A had not statistic significance(P>0.05). The incidence rate of vomiting, motor block, lethargy had not statistic significance(P>0.05) among the three group. No respiratory depression happened. Conclusion In the cesarean section PCEA, 0.4 μg/ml sufentanil combined with 0.125% ropivacaine can get better analgesic effect and less side effects.
Key words:  Epidural analgesia  Sufentanil  Cesarean section